Treatment of nail psoriasis with a modified regimen of steroid injections

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 2, 2008, Pages 78-81

  Saleem, Khawer ^a,b   Azim, Waqar ^a  

^a PNS SHIFA HOSPITAL   (Pakistan)

^b Aisha Bawany School   (Pakistan)

Author keywords

Intralesional steroids; Nail; Psoriasis

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; HYPERKERATOSIS; INJECTION SITE PAIN; INJECTION SITE PARESTHESIA; MALE; NAIL COLOR DEFECT; NAIL DYSTROPHY; ONYCHOLYSIS; PSORIASIS; PUBLIC HOSPITAL; QUASI EXPERIMENTAL STUDY; SCORING SYSTEM;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NAIL DISEASES; ONYCHOLYSIS; PROSPECTIVE STUDIES; PSORIASIS; TRIAMCINOLONE ACETONIDE;

EID: 42149131586     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Griffiths CEM, Camp RDR, Barker JNWN. Psoriasis. In: Burns T, Breatnach S, Cox N, Griffiths CEM, (edi). Rook's textbook of dermatology. Vol2. 7th ed. Oxford: Blackwell Science; 2004: p.35.1-35.69.
2. Tham SN, Lim JJ, Tay SH, Chiew YF, Chua TN, Tan E, et al. Clinical observations on nail changes in psoriasis. Ann Acad med Singapore 1998; 17: 428-5.
3. de Jong EM, Seegers BA, Gulinc KMK, Boezeman JB, van de Krekhof PC. Psoriasis of nails associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology 1996; 193: 300-3.
4. Jellinek NJ. Nail surgery: practical tips and treatment options. Dermatol Ther 2007; 20: 68-74.
5. Nicolopoulos J, Goodman GJ, Howard A. Diseases of the generative nail apparatus. Part 1: nail matrix. Australas J Dermatol 2002; 43: 81-90.
6. Lavaroni G, Kokelj F, Pauluzzi P Trevisan G. The nail in psoriatic arthritis. Acta Derm Venereol Suppl (Stockh) 1994; 186: 113.
7. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, Mc Hugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33; 834-9.
8. Comaish JS. Tar and related compounds in the therapy of psoriasis. Clin Exp Dermatol 1981; 6: 639-45.
9. Kavanagh GM, Burton JL, Donnell VO. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. Br J Dermatol 1996; 134: 234-7.
10. Corbett MF. The response of psoriasis to beta-methasone valerate and clobetasol propionate: a 6-month controlled study. Br J Dermatol 1976; 94 (Suppl 12): 89-93.
11. Kragballe K. Treatment of psoriasis by topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 1989; 125: 1647-52.
12. Van de Kerkhof PC, Werfel T, Hausten UF, Luger T, Czarnetzki BM, Niemann R, et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicente, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758-65.
13. Diluvio L, Campione E, Paterno EJ, Mordenti C, El Hachem M, Chimenti S. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. Pediatr Dermatol 2007; 24: 332-3.
14. van Weelden H, Young E, van der Leun JC. Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy. Br J Dermatol 1980; 103:1-9.
15. Roenigk HH Jr, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 1998; 38: 478-85.
16. Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, et al. Cyclosporin consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 1998; 39: 464-75.
17. Gollnick. HP. Oral retinoids-efficacy and toxicity in psoriasis. Br J Dermatol 1996; 135 (Suppl 49): 6-17.
18. Gollnick H, Bauer R, Bridley C, Orfanos CE, Plewig G, Wokalek H, et al. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. J Am Acad Dermatol 1988; 19: 458-68.
19. Schmults CA, Psoriasis confined to the nails. Dermatology Online Journal (serial on the Internet) 2003 [cited 31 Jan 2008]; 9(4):7. Available from: http://dermatology.cdlib.org/94/nyu/nov2007/8.htmal
20. Kuijpers AL, Van Pelt JP, Bergers M, Boegheim PJ, Den Bakker JE, Siegenthaler G, et al. The effects of oral liarazole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Br J Dermatol 1998; 139: 380-9.
21. de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998; 138:90-5.
22. Dawber RPR, Walker NPJ, Lawrence CM. Physical and laser therapies. In: Champion RH, Burton JL, Burns DA, Breathnach SM, (edi). Textbook of dermatology. 6th ed. London: Blackwell Science; 2004. p. 2584.
23. Curtis JA, Cormode E, Laski B, Toole J, Howard N. Endocrine complications of topical and intralesional corticosteroid therapy. Arch Dis Child 1982; 57: 204-7.
24. Van Laborde S, Scher RK. Developments in the treatment of nail psoriasis, melanonychia striata, and onychomyocosis: a review of the literature. Dermatol Clin 2000;18:37-46.
25. de Berker D. Management of nail psoriasis. Clin Exp Dermatol 2000; 25:357-62.